Main Menu

Target Validation and DNA Damage Response Team

Professor Tutt’s team interests involve the discovery of novel therapies and biomarkers in BRCA1/BRCA2-associated cancers and ER/HER2-negative/basal-like breast cancers – including the identification of new drug targets and therapy combination strategies.

Group leader

Professor Andrew Tutt

Professor Andrew Tutt

Director, Breast Cancer Now Toby Robins Research Centre

Andrew Tutt is Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Toby Robins Research Centre at the ICR and Guy’s Hospital King’s College London. He is a Clinician Scientist with the Laboratory and Clinical Trials programme, and a Consultant Clinical Oncologist looking after women with breast cancer.

ORCID 0000-0001-8715-2901

Group members

Dr Valeria Amodeo

Senior Scientific Officer +44 20 3437 6128

Anthony Cheung

Honorary Appointment

Dr Riccardo Ferro

Research Associate +44 20 3437 7039

Helen Kakkassery

Honorary Appointment

Dr Gabriel Kollarovic

Higher Scientific Officer +44 20 7153 5452

Alexia Martin

PhD Student

Dr Sarmi Nath

Postdoctoral Training Fellow +44 20 3437 6120

Blanca Navarro

Honorary Appointment

Dr Maya Raghunandan

Postdoctoral Training Fellow +44 20 7153 5423

Dr Luisa Robbez-Masson

Postdoctoral Training Fellow +44 20 7153 5054

Maya Shlomi

Scientific Officer +44 20 3437 6248

Dr Gonzalo Torga

Clinical Scientist +44 20 7153 5497

Gregory Verghese

Honorary Appointment

Dr George Vlachogiannis

Senior Scientific Officer +44 20 3437 3508

Dr Amadeus Xu

Higher Scientific Officer +44 20 3437 6048

Dr Jason Yeung

Clinical Research Fellow